ライフサイエンスコーパス: therapeutic approaches

1 ations in patients with NS indicates an urgent need for new therapeutic approaches.

2 dent disease phenotypes and provide avenues for alternative therapeutic approaches.

3 t a suitable therapeutic option in the absence of any other therapeutic approaches.

4 drugs, nutrients, and pre- or probiotics might offer better therapeutic approaches.

5 the characteristics necessary for potential prophylactic or therapeutic approaches.

6 udy highlights XPB as a novel drug target in block-and-lock therapeutic approaches.

7 re promotes GBM invasiveness may help to develop innovative therapeutic approaches.

8 allograft-infiltrating recipient immune cells and potential therapeutic approaches.

9 erstanding the mechanism behind this disease and developing therapeutic approaches.

10 tivation by targeting its repressor EMI1 are both potential therapeutic approaches.

11 sant effects of standard or novel (e.g., anti-inflammatory) therapeutic approaches.

12 e(3-5) and provides a resource for the development of novel therapeutic approaches.

13 symptoms particularly difficult to manage with traditional therapeutic approaches.

14 disease progression, and development and monitoring of new therapeutic approaches.

15 hat initiate ventricular tachycardia, and regarding optimal therapeutic approaches.

16 is a key aspect of diseased tissues, and the most promising therapeutic approaches aim to lower expanded HTT levels.

17 Hence, we identify new therapeutic targets and putative therapeutic approaches aimed at resolving detrimental myeloid

18 Therapeutic approaches aiming to destabilize MYCN protein, su

19 In turn, this discussion promotes consideration of therapeutic approaches, an issue that becomes more directed i

20 his variation could lead to the development of personalized therapeutic approaches and improve treatment outcomes.

21 and technical breakthroughs that can be applied to existing therapeutic approaches and to the development of novel cuttin

22 BACKGROUNDNovel therapeutic approaches are critically needed for Staphylococc

23 patients with relapsed disease remains poor, and thus novel therapeutic approaches are needed.

24 orders, focusing on their clinical features, diagnostic and therapeutic approaches are presented.

25 yl signaling pathways and they hold the potential for novel therapeutic approaches as well as a deeper understanding of A

26 Finally, we outline current therapeutic approaches designed to circumvent venom variation

27 targeting ChIs with channel-specific modulators may provide therapeutic approaches for alleviating L-DOPA-induced dyskine

28 ature of hantavirus-induced glomerulopathy may generate new therapeutic approaches for INS.

29 mon phenotype, and emphasize the potential for personalized therapeutic approaches for slowing clinical progression of AD

30 However, physiologic mechanisms should exist and therapeutic approaches may be developed to balance between ag

31 We also describe recent therapeutic approaches targeting adhesion molecules.

32 Our results provide rationale for novel therapeutic approaches targeting HIV cure and, more generally

33 However, therapeutic approaches targeting senescence-associated CSCs r

34 mechanisms of action of MAC provide an updated framework to therapeutic approaches that can target MAC assembly, signalin

35 se as populations continue to age, yet there are no current therapeutic approaches that delay or stop disease progression

36 COVID-19 dyslipidemia and propose possible adjunctive type therapeutic approaches that modulate lipids and lipoproteins.

37 Novel therapeutic approaches that successfully target AR-SVs may be

38 as unique features that make this malignancy attractive for therapeutic approaches that target components of the immune s

39 genetic and environmental factors underlying HF, and novel therapeutic approaches to address it, are urgently warranted.

40 H, while suggesting that modulating this draining may offer therapeutic approaches to alleviate SAH severity.

41 Therapeutic approaches to combat type 1 diabetes (T1D) includ

42 th SLE affect cell metabolism, and the development of novel therapeutic approaches to control the activity of metabolic e

43 is unique and versatile cell will undoubtedly lead to novel therapeutic approaches to metabolic and age-related disorders

44 aintained LV function and may contribute to designing novel therapeutic approaches to prevent cardiac dysfunction in diab

45 e form, nonalcoholic steatohepatitis (NASH), requires novel therapeutic approaches to prevent disease progression.

46 g TBI suggests this model may be beneficial for testing new therapeutic approaches to prevent SoT.

47 ntagonists or serotonin reuptake inhibitors could represent therapeutic approaches to reduce neutrophil activation in SCA

48 tic infections and epilepsy, and we consider preventive and therapeutic approaches to reduce the burden of epilepsy attri

49 Thus, the model can help to identify and test novel therapeutic approaches to restore the impaired epithelial rep

50 Ss in viral pathogenesis but also suggests potential future therapeutic approaches to treat SFTSV-infected patients.